JP2022549353A5 - - Google Patents

Info

Publication number
JP2022549353A5
JP2022549353A5 JP2022519324A JP2022519324A JP2022549353A5 JP 2022549353 A5 JP2022549353 A5 JP 2022549353A5 JP 2022519324 A JP2022519324 A JP 2022519324A JP 2022519324 A JP2022519324 A JP 2022519324A JP 2022549353 A5 JP2022549353 A5 JP 2022549353A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
optionally substituted
independently
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022519324A
Other languages
English (en)
Japanese (ja)
Other versions
JP7753201B2 (ja
JP2022549353A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/052545 external-priority patent/WO2021062030A1/en
Publication of JP2022549353A publication Critical patent/JP2022549353A/ja
Publication of JP2022549353A5 publication Critical patent/JP2022549353A5/ja
Priority to JP2025165441A priority Critical patent/JP2025186528A/ja
Application granted granted Critical
Publication of JP7753201B2 publication Critical patent/JP7753201B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022519324A 2019-09-24 2020-09-24 プロテインキナーゼc(pkc)に作用するジテルペノイド化合物 Active JP7753201B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025165441A JP2025186528A (ja) 2019-09-24 2025-10-01 プロテインキナーゼc(pkc)に作用するジテルペノイド化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962905253P 2019-09-24 2019-09-24
US62/905,253 2019-09-24
PCT/US2020/052545 WO2021062030A1 (en) 2019-09-24 2020-09-24 Diterpenoid compounds that act on protein kinase c (pkc)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025165441A Division JP2025186528A (ja) 2019-09-24 2025-10-01 プロテインキナーゼc(pkc)に作用するジテルペノイド化合物

Publications (3)

Publication Number Publication Date
JP2022549353A JP2022549353A (ja) 2022-11-24
JP2022549353A5 true JP2022549353A5 (cg-RX-API-DMAC10.html) 2023-09-06
JP7753201B2 JP7753201B2 (ja) 2025-10-14

Family

ID=75165333

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022519324A Active JP7753201B2 (ja) 2019-09-24 2020-09-24 プロテインキナーゼc(pkc)に作用するジテルペノイド化合物
JP2025165441A Pending JP2025186528A (ja) 2019-09-24 2025-10-01 プロテインキナーゼc(pkc)に作用するジテルペノイド化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025165441A Pending JP2025186528A (ja) 2019-09-24 2025-10-01 プロテインキナーゼc(pkc)に作用するジテルペノイド化合物

Country Status (9)

Country Link
US (1) US20220411362A1 (cg-RX-API-DMAC10.html)
EP (1) EP4041268A4 (cg-RX-API-DMAC10.html)
JP (2) JP7753201B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220116143A (cg-RX-API-DMAC10.html)
CN (1) CN114786697A (cg-RX-API-DMAC10.html)
AU (1) AU2020352641B2 (cg-RX-API-DMAC10.html)
CA (1) CA3155650A1 (cg-RX-API-DMAC10.html)
IL (1) IL291697B2 (cg-RX-API-DMAC10.html)
WO (1) WO2021062030A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3212440A1 (en) * 2021-03-23 2022-09-29 Ruihong Chen Diterpenoid compounds that act on protein kinase c (pkc)
WO2023033128A1 (ja) * 2021-09-03 2023-03-09 国立大学法人京都大学 タンパク質の製造方法
JP2025505797A (ja) * 2022-02-17 2025-02-28 キューバイオティクス プロプライアタリー リミティド 併用療法
WO2025226622A1 (en) * 2024-04-22 2025-10-30 The Board Of Trustees Of The Leland Stanford Junior University Tigilanol tiglate analogs, phorbol analogs, prodrugs, synthetic methods, and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063814A (en) 1997-04-14 2000-05-16 Chang; Richard L. Phorbol esters as anti-neoplastic and white blood cell elevating agents
JP2008051589A (ja) * 2006-08-23 2008-03-06 Shiseido Co Ltd ホルボール抗原
US8816122B2 (en) * 2009-07-20 2014-08-26 The Board Of Trustees Of The Leland Stanford Junior University Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use
WO2013071282A1 (en) * 2011-11-13 2013-05-16 Blanchette Rockefeller Neurosciences Institute Pkc activators and combinations thereof
BR112014017716A8 (pt) 2012-01-18 2021-03-02 Biosuccess Biotech Co Ltd composições de ésteres de forbol, métodos para prevenir ou tratar acidente vascular cerebral e uso de ésteres de forbol
AU2015314979A1 (en) * 2014-09-10 2017-03-02 The Regents Of The University Of California Targeting K-Ras-mediated signaling pathways and malignancy by prostratin
MA40904A (fr) 2014-11-03 2017-09-12 Hygeia Tech Inc Compositions d'ester de phorbol et procédés pour traiter ou réduire la durée d'une cytopénie
WO2017062924A1 (en) * 2015-10-08 2017-04-13 Alkon Daniel L Dosing regimens of pkc activators
US10722484B2 (en) * 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
CA3212440A1 (en) * 2021-03-23 2022-09-29 Ruihong Chen Diterpenoid compounds that act on protein kinase c (pkc)

Similar Documents

Publication Publication Date Title
JP2025160318A5 (cg-RX-API-DMAC10.html)
ES2657014T3 (es) Péptidos citotóxicos y conjugados de fármaco anticuerpo de los mismos
JP2025160317A5 (cg-RX-API-DMAC10.html)
RU2662951C2 (ru) Производные доластатина 10 и ауристатинов
CA2935077C (en) Sulfonamide-containing linkage systems for drug conjugates
JP2021152063A5 (cg-RX-API-DMAC10.html)
ES3013661T3 (en) Affinity medicant conjugates
IL291697B2 (en) Diterpenoid compounds acting on protein kinase (pkc c)
JPWO2020122034A5 (cg-RX-API-DMAC10.html)
JP2022537158A5 (cg-RX-API-DMAC10.html)
HUT72440A (en) Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them
IL108999A (en) Nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
JP2016505513A5 (cg-RX-API-DMAC10.html)
HRP20220550T1 (hr) Imunokonjugati koji ciljaju adam9 i postupci njihove uporabe
JP2018058822A5 (cg-RX-API-DMAC10.html)
JP7334147B2 (ja) 炭酸脱水酵素陽性がんを標的とするfbsa系治療および放射性造影複合体
WO2000044770A1 (en) Substituted phenethylamine derivatives
JP2017518363A5 (cg-RX-API-DMAC10.html)
JPH0523260B2 (cg-RX-API-DMAC10.html)
JP2022546807A5 (cg-RX-API-DMAC10.html)
JP2016536372A5 (cg-RX-API-DMAC10.html)
ES2883023T3 (es) Derivados de péptidos de dolaproína-dolaisoleuina citotóxicos para el tratamiento del cáncer
JP2026501817A (ja) リガンド-薬物コンジュゲート
JP2024512046A5 (cg-RX-API-DMAC10.html)
RU2008152813A (ru) Пептиды с антипролиферативной активностью